Find Tulobuterol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 41570-61-0, 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol, Atenos, C-78 (free base), 2-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol, 591i9su0f7
Molecular Formula
C12H18ClNO
Molecular Weight
227.73  g/mol
InChI Key
YREYLAVBNPACJM-UHFFFAOYSA-N
FDA UNII
591I9SU0F7

Tulobuterol
Tulobuterol has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.
1 2D Structure

Tulobuterol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(tert-butylamino)-1-(2-chlorophenyl)ethanol
2.1.2 InChI
InChI=1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3
2.1.3 InChI Key
YREYLAVBNPACJM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C)NCC(C1=CC=CC=C1Cl)O
2.2 Other Identifiers
2.2.1 UNII
591I9SU0F7
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(o-chlorophenyl)-2-tert-butylaminoethanol

2. Alpha-((tert-butylamino)methyl)-o-chlorobenzyl Alcohol

3. Atenos

4. Brelomax

5. C-78

6. Hn-078

7. Tulobuterol Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 41570-61-0

2. 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol

3. Atenos

4. C-78 (free Base)

5. 2-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol

6. 591i9su0f7

7. Chlibamol

8. Bremax

9. Nsc-758643

10. Hokunalin (tn)

11. (+/-)-tulobuterol

12. Tulobuterolum

13. 2-chloro-alpha-[[(1,1-dimethylethyl)amino]methyl]benzenemethanol

14. Tulobuterolum [inn-latin]

15. .alpha.-[(tert-butylamino)methyl]-o-chlorobenzyl Alcohol

16. Tulobuterol [inn:ban:jan]

17. Unii-591i9su0f7

18. .alpha.-((tert-butylamino)methyl)-o-chlorobenzyl Alcohol

19. 2-tert-butylamino-1-(2-chlorphenyl)ethanol

20. Atenos (tn)

21. Hn 078

22. Alpha-((tert-butylamino)methyl)-o-chlorobenzyl Alcohol

23. Spectrum_001648

24. Tulobuterol [mi]

25. Spectrum2_001616

26. Spectrum3_001900

27. Spectrum4_000206

28. Spectrum5_001285

29. Tulobuterol [inn]

30. Tulobuterol [jan]

31. Tulobuterol (jp17/inn)

32. Lopac0_001149

33. Bspbio_003440

34. Kbiogr_000811

35. Kbioss_002128

36. Tulobuterol [who-dd]

37. Divk1c_000712

38. Schembl122692

39. Spbio_001651

40. Chembl1159717

41. Dtxsid7048457

42. Chebi:93856

43. Kbio1_000712

44. Kbio2_002128

45. Kbio2_004696

46. Kbio2_007264

47. Kbio3_002943

48. Ninds_000712

49. Hms2090e11

50. Hms3715j21

51. Amy11155

52. Hy-b1810

53. Bdbm50421717

54. Mfcd00867022

55. Akos010122688

56. Ccg-205223

57. Db12248

58. Nsc 758643

59. Sdccgsbi-0051116.p004

60. Idi1_000712

61. Ncgc00016034-02

62. Ncgc00016034-03

63. Ncgc00016034-09

64. Ncgc00162354-01

65. As-10998

66. Sbi-0051116.p003

67. Db-050772

68. Tulobuterol 1000 Microg/ml In Acetonitrile

69. Cs-0013856

70. Vu0244437-2

71. D02151

72. F17342

73. Ab00053692-02

74. Ab00053692_03

75. 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol #

76. 570t610

77. L013403

78. Q909353

79. 2-(tert-butylamino)-1-(2-chlorophenyl)ethan-1-ol

80. Q-201905

81. Sr-01000076165-4

82. Brd-a37441042-003-02-2

83. 2-chloro-.alpha.-[[(1,1-dimethylethyl)amino]methyl]benzenemethanol

84. (rs)-2-tert-butylamino-1 -phenil Ethanol Monohydrochloride; O-chloro-?-[(tert-butylamino)methyl]benzyl Alcohol Hydrochloride; (+/-)-tulobuterol Hydrochloride

85. 1-(2-chlorophenyl)-2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]ethanol

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 227.73 g/mol
Molecular Formula C12H18ClNO
XLogP32.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count4
Exact Mass227.1076919 g/mol
Monoisotopic Mass227.1076919 g/mol
Topological Polar Surface Area32.3 Ų
Heavy Atom Count15
Formal Charge0
Complexity191
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Episodic wheeze, Asthma


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Adrenergic beta-Agonists

Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)


Bronchodilator Agents

Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)


5.2 ATC Code

R - Respiratory system

R03 - Drugs for obstructive airway diseases

R03A - Adrenergics, inhalants

R03AC - Selective beta-2-adrenoreceptor agonists

R03AC11 - Tulobuterol


R - Respiratory system

R03 - Drugs for obstructive airway diseases

R03C - Adrenergics for systemic use

R03CC - Selective beta-2-adrenoreceptor agonists

R03CC11 - Tulobuterol


Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty